Table 3.
All (n = 365) | Conventional ≥ 50% stenosis (n = 266) | Near-occlusion without full collapse (n = 57) | Near-occlusion with full collapse (n = 42) | |||||
---|---|---|---|---|---|---|---|---|
n | % Risk (95% CI) | n | % Risk (95% CI) | n | % Risk (95% CI) | n | % Risk (95% CI) | |
Primary endpoint—ipsilateral ischemic stroke or retinal artery occlusion | ||||||||
2 days | 17 | 5 (3–7) | 5 | 2 (0–3) | 4 | 7 (0–14) | 6 | 14 (4–25) |
7 days | 27 | 8 (5–10) | 12 | 5 (2–7) | 6 | 11 (3–19) | 9 | 21 (9–34) |
14 days | 35 | 11 (7–14) | 19 | 9 (5–13) | 6 | 11 (3–19) | 10 | 24 (11–37) |
30 days | 39 | 13 (9–17) | 21 | 10 (6–15) | 7 | 16 (3–29) | 11 | 27 (13–40) |
90 days | 46 | 17 (13–22) | 26 | 15 (9–20) | 8 | 22 (6–38) | 12 | 30 (16–44) |
Secondary endpoint—ipsilateral ischemic stroke | ||||||||
2 days | 16 | 4 (2–7) | 5 | 2 (0–3) | 3 | 5 (0–11) | 6 | 14 (4–25) |
7 days | 26 | 7 (5–10) | 12 | 5 (2–7) | 5 | 9 (2–16) | 9 | 21 (9–34) |
14 days | 34 | 11 (7–14) | 19 | 9 (5–13) | 5 | 9 (2–16) | 10 | 24 (11–37) |
30 days | 38 | 13 (9–17) | 21 | 10 (6–15) | 6 | 14 (2–26) | 11 | 27 (13–40) |
90 days | 45 | 17 (12–22) | 26 | 15 (9–20) | 7 | 20 (4–35) | 12 | 30 (16–44) |
Secondary endpoint—ipsilateral ischemic stroke, TIA, retinal artery occlusion or amaurosis fugax | ||||||||
2 days | 49 | 13 (10–17) | 33 | 12 (8–16) | 6 | 11 (2–19) | 10 | 24 (11–37) |
7 days | 71 | 20 (16–24) | 48 | 19 (14–23) | 10 | 18 (8–28) | 13 | 31 (17–45) |
14 days | 82 | 24 (19–29) | 54 | 22 (17–27) | 14 | 28 (15–41) | 14 | 34 (19–48) |
30 days | 87 | 27 (22–32) | 57 | 24 (19–30) | 15 | 33 (18–48) | 15 | 36 (22–51) |
90 days | 96 | 32 (26–38) | 64 | 30 (23–36) | 16 | 38 (21–56) | 16 | 39 (24–55) |
Based on Kaplan–Meier estimates